Mini Review - Interventional Cardiology (2022)
A focus on the remarkable add-on value of chronic total occlusion guidewires in the armamentarium of atretic pulmonary valve perforation
- Corresponding Author:
- Raymond N. Haddad
Department of Pediatric Cardiology,
Hotel Dieu de France University Medical Center,
Saint Joseph University,
Beirut,
Lebanon,
E-mail: raymondhaddad@live.com
Received date: 05-Apr-2022, Manuscript No. FMIC-22-59546; Editor assigned: 07-Apr-2022, PreQC No. FMIC-22-59546 (PQ); Reviewed date: 25-Apr-2022, QC No. FMIC-22-59546; Revised date: 02-May-2022, Manuscript No. FMIC-22-59546 (R); Published date: 09-May-2022, DOI: 10.37532/1755-5310.2022.14(S10).242
Abstract
Continuous advances in the technology of Chronic Total Occlusion (CTO) hardware have led to the development of a wide range of specialty guidewires with increased maneuverability, tip support, torque force, and penetrating power. We and other congenital interventionists described the safe, efficient, and effective use of CTO wires in percutaneous Pulmonary Valve (PV) mechanical perforations. Consecutive reports highlighted the importance of these CTO wires in the armamentarium and discussed their high potential in substituting other methods of endovascular perforation. Herein, we will review the reported experiences with CTO wires and discuss the procedural advantages and technical aspects of these wires in transcatheter treatment of Pulmonary Atresia with Intact Ventricular Septum (PA/IVS).
Keywords
Congenital heart disease • Chronic total occlusion • Coronary wires • Transcatheter interventions • Valve perforation
Abbreviations
CHD: Congenital Heart Disease; CTO: Chronic Total Occlusion; PA/IVS: Pulmonary Atresia with Intact Ventricular Septum; PCI: Percutaneous Coronary Intervention; PV: Pulmonary Valve
Introduction
Multidisciplinary collaboration is essential to promote innovation, optimization of techniques, and development of medical devices for tailored patient care. In particular, close interaction between specialists in the catheter-based treatment of coronary, congenital, structural, and valvular heart disease has been extending the armamentarium over the years and widening the horizon. The examples are numerous and in both directions. Structural heart specialists were inspired by the Melody valve project, conceived by their colleagues, congenital interventionalists, in 2000, to implement the same idea in transcatheter aortic valve implantations [1,2]. Likewise, but in the other direction, congenital interventionalists used coronary stents to maintain the ductal patency in ductal dependent circulations [3]. More recently, there has been an introduction of CTO wires, originally designed for complex Percutaneous Coronary Interventions (PCIs), into the field of congenital heart interventions [4]. The CTO wires have evolved substantially over the past decade and became of paramount help for interventionists working in resource-limited countries to substitute the sophisticated radiofrequency systems. We and others reported successful and complication-low experiences in endovascular perforation, pushing interventionists in well-equipped centers to use these CTO wires as a first choice in their interventions [4-10]. In this mini review, we will go through the reported experiences with CTO wires and detail the technical aspects of these wires for congenital interventionalists dealing with atretic PVs.
Literature Review
General characteristics of CTO wires
A wide range of CTO wires with different tip angles, weights, and penetration forces are available and commonly employed in PCIs. These specialty CTO guidewires differ from other more common coronary guidewires by their heavy tips. They are placed into an exact area that is desired to be perforated and then they are pushed gently with drilling manoeuvers, which is sufficient to have successful results. Various terminologies are utilized when discussing CTO wires: penetrability, pushability, trackability, torquability, steerability, and lubricity [11]. According to these terminologies, the success of the process depends on the type of CTO wire, lateral support of the wire, and the resistance encountered in the lesion. When selecting a CTO wire, the penetration power is mainly taken into account (Table 1). The penetrability depends on the tip load, tapered tip design, wire support (microcatheter and anchoring techniques), and lateral support of the wire. Crossability is better with tapered tips than with straight tips, although the latter give a better tactile feeling feedback. According to the resistance encountered in the tissue, two types of CTO wires are currently available: polymer-coated (hydrophilic) wires and uncoated (hydrophobic) coil wires [11,12]. Hydrophilic wires attract very little resistance when they come in contact with tissue in the lumen. These wires move easily through soft tissue, follow the path of least resistance, and therefore have a potential risk to go extra-luminal. These wires are softer, offer good maneuverability, may find microchannels easier (especially with tapered tips), and are preferred mostly in tortuous clogged lesions. On the other hand, hydrophobic wires offer less maneuverability but provide a better tactile response with good resistance and torquability. These characteristics make hydrophobic wires preferable in hard and fully occluded lesions.
Guidewire | Manufacturer | Coating | Cover type or coils | Tip radiopacity (cm) | Tip stiffness (Load) (g) | Tip diameter (in) | Penetration Power (Kg/in2) |
---|---|---|---|---|---|---|---|
Shinobi | Cordis | Hydrophobic | Polymer wrapped | 3 | 6.8 | 0.014 | 44 |
Shinobi Plus | Cordis | Hydrophobic | Polymer wrapped | 3 | 7 | 0.014 | 45 |
MiracleBros 3 | Asahi Intecc | Hydrophobic | Silicone coating | 11 | 3 | 0.014 | 32 |
MiracleBros 6 | Asahi Intecc | Hydrophobic | Silicone coating | 11 | 6 | 0.014 | 72 |
MiracleBros 12 | Asahi Intecc | Hydrophobic | Silicone coating | 11 | 12 | 0.014 | 106 |
Conquest 9 | Asahi Intecc | Hydrophobic | Silicone coating | 20 | 9 | 0.009 | 135 |
Conquest Pro 9 | Asahi Intecc | Hydrophilic | SLIP COAT coating, excluding the tip | 20 | 9 | 0.009 | 146 |
Conquest Pro 12 | Asahi Intecc | Hydrophilic | SLIP COAT coating, excluding the tip | 20 | 12 | 0.009 | 195 |
Conquest Pro 8-20 | Asahi Intecc | Hydrophilic | SLIP COAT coating, excluding the tip | 17 | 20 | 0.008 | |
PILOT 150 | Abbott Vascular | Hydrophilic | Full polymer cover | 3 | 2.5 | 0.014 | |
PILOT 200 | Abbott Vascular | Hydrophilic | Full polymer cover | 3 | 3.9 | 0.014 | |
CROSS-IT 100XT | Abbott Vascular | Hydrophilic | Bare coils | 3 | 1.6 | 0.0105 | 20 |
CROSS-IT 200XT | Abbott Vascular | Hydrophilic | Bare coils | 3 | 4.4 | 0.0105 | 54 |
CROSS-IT 300XT | Abbott Vascular | Hydrophilic | Bare coils | 3 | 7.1 | 0.0105 | 72 |
CROSS-IT 400XT | Abbott Vascular | Hydrophilic | Bare coils | 3 | 10.9 | 0.0105 | 101 |
PROGRESS 40 | Abbott Vascular | Hydrophilic | Intermediate polymer cover | 3 | 5 | 0.012 | 40 |
PROGRESS 80 | Abbott Vascular | Hydrophilic | Intermediate polymer cover | 3 | 11.5 | 0.012 | 80 |
PROGRESS 120 | Abbott Vascular | Hydrophilic | Intermediate polymer cover | 3 | 17.5 | 0.012 | 120 |
PROGRESS 140 T | Abbott Vascular | Hydrophilic | Intermediate polymer cover | 3 | 15.5 | 0.0105 | 140 |
PROGRESS 200 T | Abbott Vascular | Hydrophilic | Intermediate polymer cover | 3 | 13.5 | 0.009 | 200 |
Table 1: CTO wires properties.
Introduction of CTO wires in transcatheter treatment of PA/ IVS
In 1991, Qureshi, et al. and Parsons, et al. first used laser-heated wires to perforate atretic PVs and since then transcatheter interventions became the cornerstone of treatment of selected PA/IVS cases with suitable anatomy for biventricular circulation [13,14]. In the same year, Latson LA performed the first case of PV opening with the stiff-tip of a 0.014” coronary guidewire [15]. In 1993, Rosenthal, et al. reported that laser-assisted PV perforation might significantly lead to deadly heart misperforations [16]. Shortly after, the same team reported on the efficacy and safety of the radiofrequency-assisted PV perforation [17]. With cumulative experience, radiofrequency perforation became the most accepted method for dealing with this anomaly and has been routinely applied in most centers. However, cost and availability constraints of equipment limited its usage in resource-limited countries and motivated the search for different perforation techniques. In recent years, it turned out that stiff-tip wire perforation is risky and technically challenging due to less control on the perforating system [9]. Meanwhile, interventionists have been discussing the novel use of CTO wires as a safe and effective technique [4-10], and sometimes as a better performing alternative to radiofrequency perforation [5,10].
Discussion
Advantages and technical aspects of CTO wires for antegrade perforation in PA/IVS
The use of CTO wire for PV perforation is thought as a good alternative given its peculiar property called “penetration power.” According to the literature, the reported procedural success rate with CTO wires were so far 77% [10], 80% [7], 87.5% [4], 89% [6], and 100% [8,9]. To achieve successful perforations, close, stable, and continuous contact of the catheter tip with the plane of the PV is mandatory so that the torque force of the CTO wire is directly transmitted forward to the target zone. Compared to 5-Fr catheters, 4-Fr catheters are softer, less bulky, and much easier to manipulate in neonatal hearts, particularly in patients with PA/ IVS who present with tricuspid regurgitation, right ventricular hypertrophy, and/or hypoplasia. However, 5-Fr catheters offer better catheter support and improved wire torquability and have lower odds of pointing the perforation wire in a superior and anterior direction. Therefore, we recommend the use of 5-Fr JR coronary catheters and taking time in centering the catheters in front of the atretic PV thereby achieving the optimal coaxial alignment of catheters before perforation [6,9,18].
In comparison to radiofrequency wires and stiff-tip of classic coronary wires, the floppy tip of CTO wires will not displace the catheters when they are being pushed forward across the atretic PVs. This important advantage has been reported by Alwi, et al. and contributes to the controlled penetrability, augmented precision, and straight-forward pushability of CTO wires that significantly reduced perforation time [4]. After successful valve perforation, it is possible, due to advanced steerability, to guide some CTO wires directly into a descending aorta through the arterial duct and less commonly into a distal branch pulmonary artery without any snare assistance [10]. In our experience, we favored the use of highly penetrating CTO wires, and thereby we did not steer these wires into a distal vessel because the excessive penetration force of CTO wires, although assumed safe, could lead to the dissection or perforation of soft vessels in neonates. Some interventionists proceed by advancing the floppy tip of a classic coronary 0.014” guidewire alongside the CTO wire that is subsequently removed [10]. Other interventionists created a telescopic system with a CTO guidewire, a microcatheter, and a 5-Fr catheter, and reported that microcatheters can stabilize the catheter, increase wire support and perforation power, and finally allow easier wire exchanges [8]. In our experience, we always implemented snare assistance for several reasons [9]. A single-loop or even better a three-loop 4-FR snare catheter, retrogradely routed through the arterial duct and positioned just above the plane of the atretic valve, will first serve as a fixed target for drilling, reducing repetitive hand-contrast controls and the risk of inadvertent misperforations [6,9,18]. The snare will sit in the pulmonary sinus and courses into the posterior inferior plane of the main pulmonary artery and arterial duct preventing any blind perforation attempt. This snare catheter will also allow an immediate catch of the CTO floppy tip within the pulmonary artery lumen, confirming the perforation success, stabilizing the assembly, and assisting the safe advancement of the wire tip into the descending aorta, thereby creating an arteriovenous circuit. This arteriovenous circuit will allow fast and secure delivery of a single valvuloplasty balloon of target diameter into position avoiding unnecessary predilation with smaller coronary balloons [18].
In PA/IVS, the membranous atretic tissues consistency is different from the fibrous cap in coronary CTOs and the thickness might vary from one patient to another. The strategies involved in perforation include drilling, penetrating, and sliding. The drilling process implies a gradual step-up of the wire stiffness and relies on the visual as well as the tactile feedback information from the wire tip. It is very important to be patient and manipulate the CTO guidewires gently because perforation time varied from 1 minute up to 15 minutes in our experience. The comparison of different CTO wires is not reasonable given the limited number of recruited patients in the literature. Patil, et al. highlighted the utility of the tapered tip design that amplifies the capacity of the wire to lock and puncture while being submitted to a rotational movement with the support of a catheter next to the membrane which is going to be perforated [6]. Alwi, et al. successfully used the Conquest Pro CTO wires to perforate the PV in 7/8 cases without any complications [4]. Kamali, et al. reported the use of low-penetration wires and the rate of successful perforations was 77% [10]. Bakhru, et al. reported the use of high-penetration wires after unsuccessful perforation with low-penetration wires. They also concluded that the predictability of CTO wires with low-penetration power is uncertain while hydrophilic wires and those with higher tip load were associated with higher success rates [7]. On the other side, Patil, et al. discussed that hydrophilic wires may not be useful in PA/IVS and have an increased risk of causing misperforation because of less tactile feeling [6]. Their preferred guidewires were straight-tipped MiracleBros 12 or the tapered-tipped Conquest 9, CROSS-IT 400 XT, Conquest Pro 9, and Conquest Pro 12. The straight-tipped Miracle guidewires exhibit better torque, crushing force, and tactile feeling but lesser penetration force when compared to the tapered-tipped Conquest guidewires. In our experience, we achieved one successful perforation using a less powerful but thinner hydrophilic CROSS-IT 200 XT after the failure of the powerful hydrophobic MiracleBros 12 [9]. Wire tips, generally defined as the distal few centimetres, are the most complex assemblies in coronary wires and play the biggest role in determining the performance features discerned by interventionists [19]. For any given value of bending stiffness, reduced tip designs can generate higher penetrating pressure that can be exerted by the tip to penetrate soft tissue within an occlusion. When pushed against membranous pulmonary atresia, this property might improve the ability of the wire to pierce forward in a directed fashion and reduce the potential risk of severe pericardial effusion in the event of unintended misperforation [4]. Wire tip diameter might inherently play an important additional role in the presence of a tiny angiographically unidentified hole.
The risk of misperforations with CTO wires is not inexistent in published series. However, CTO wire misperforation is usually limited to a tiny hole while the radiofrequency wire has the capability of not only misperforating but also slicing the tissues, thus creating a sizable misperforation with rapid progression to tamponade. In our experience and recently reported experiences, the proper use of CTO wires for PV perforation is safe and complication-free [8,9]. The snare assistance technique increases the safety of the procedure. However, caution should always be taken, ensuring that coated stents and a surgery team are kept ready in case of life-threatening complications.
Potential use of CTO wires in congenital heart interventions
Indications of vascular perforations in CHD interventions are not infrequent. Nowadays, the most current indication is PV perforation in neonates with PA/IVS. Less common transcatheter indications include perforation of functionally interrupted aorta, occluded caval veins or caval baffles, and creation of cavopulmonary anastomosis or reverse Potts shunts [20]. To our knowledge, CTO wires have been applied so far in one case of perforation of a functionally interrupted aorta after the failure of radiofrequency wires [21]. CTO wires have been also used for the restoration of caval veins patency and in some challenging septal anatomies during patent foramen ovale closures (unpublished reports).
Conclusion
The introduction of affordable and accessible CTO wires with subsequent technique modifications revolutionized the PV perforation procedure in PA/IVS patients with safe outcomes and like high success rate in comparison to the one reported with radiofrequency or other techniques. Appropriate patient and hardware selection remains the cornerstone of the procedure. The application of CTO wires in the treatment of other stenotic and occluded vascular lesions is expected in congenital heart interventions and should be promoted.
Author Contributions
RH designed the manuscript and took the lead in writing it entirely. Both authors have critically read and approved the final version of the manuscript.
Financial Support
None.
Conflict of Interest
Z.Saliba is a proctor and consultant for Abbott Vascular andLifetech. R. Haddad has no conflict of interest to declare.
References
- Bonhoeffer P, Boudjemline Y, Saliba Z, et al. Percutaneous replacement of pulmonary valve in a right-ventricle to pulmonary-artery prosthetic conduit with valve dysfunction. Lancet. 356(9239): 1403-5 (2000).
[CrossRef] [Google Scholar] [PubMed]
- Cribier A, Eltchaninoff H, Bash A, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: First human case description. Circulation. 106(24): 3006-8 (2002).
[CrossRef] [Google Scholar] [PubMed]
- Haddad RN, Hanna N, Charbel R, et al. Ductal stenting to improve pulmonary blood flow in pulmonary atresia with intact ventricular septum and critical pulmonary stenosis after balloon valvuloplasty. Cardiol Young. 29(4): 492-498 (2019).
[CrossRef] [Google Scholar] [PubMed]
- Alwi M, Budi RR, Mood MC, et al. Pulmonary atresia with intact septum: The use of Conquest Pro coronary guidewire for perforation of atretic valve and subsequent interventions. Cardiol Young. 23(2):197-202 (2013).
[CrossRef] [Google Scholar] [PubMed]
- Tanıdır IC, Oztürk E, Güzeltaş A, et al. Radiofrequency resistant pulmonary atresia with intact septum: The use of Conquest Pro 12 coronary guidewire. Turk Kardiyol Dern Ars. 42(6): 568-70 (2014).
[CrossRef] [Google Scholar] (All versions) [PubMed]
- Patil NC, Saxena A, Gupta SK, et al. Perforating the atretic pulmonary valve with CTO hardware: Technical aspects. Catheter Cardiovasc Interv. 88(5): E145-E150 (2016).
[CrossRef] [Google Scholar] [PubMed]
- Bakhru S, Marathe S, Saxena M, et al. Transcatheter pulmonary valve perforation using chronic total occlusion wire in pulmonary atresia with intact ventricular septum. Ann Pediatr Cardiol. 10(1): 5-10 (2017).
[CrossRef] [Google Scholar] [PubMed]
- Lefort B, Saint-Etienne C, Soulé N, et al. Perforation of the atretic pulmonary valve using Chronic Total Occlusion (CTO) wire and coronary microcatheter. Congenit Heart Dis. 14(5): 814-818 (2019).
[CrossRef] [Google Scholar] [PubMed]
- Haddad RN, Saliba Z. Optimal management of pulmonary atresia with intact ventricular septum in a developing country: The art of pulmonary valve mechanical perforation in the era of CTO hardware. Am J Cardiovasc Dis. 11(1): 21-28 (2021).
[Google Scholar] [PubMed]
- Kamalı H, Tanıdır İC, Erdem A, et al. The use of Chronic Total Occlusion (CTO) wires for perforation of atretic pulmonary valve; two centers experience. Pediatr Cardiol. 42(5):1041-1048 (2021).
[CrossRef] [Google Scholar] [PubMed]
- Mishra S. Language of CTO interventions: Focus on hardware. Indian Heart J. 68(4): 450-63 (2016).
[CrossRef] [Google Scholar] [PubMed]
- Touma G, Ramsay D, Weaver J. Chronic total occlusions: Current techniques and future directions. Int J Cardiol Heart Vasc. 7: 28-39 (2015).
[CrossRef] [Google Scholar] [PubMed]
- Qureshi SA, Rosenthal E, Tynan M, et al. Transcatheter laser-assisted balloon pulmonary valve dilation in pulmonic valve atresia. Am J Cardiol. 67(5): 428-31 (1991).
[CrossRef] [Google Scholar] [PubMed]
- Parsons JM, Rees MR, Gibbs JL. Percutaneous laser valvotomy with balloon dilatation of the pulmonary valve as primary treatment for pulmonary atresia. Br Heart J. 66(1): 36-8 (1991).
[CrossRef] [Google Scholar] [PubMed]
- Latson LA. Nonsurgical treatment of a neonate with pulmonary atresia and intact ventricular septum by transcatheter puncture and balloon dilation of the atretic valve membrane. Am J Cardiol. 68(2): 277-9 (1991).
[CrossRef] [Google Scholar] [PubMed]
- Rosenthal E, Qureshi SA, Kakadekar AP, et al. Technique of percutaneous laser-assisted valve dilatation for valvar atresia in congenital heart disease. Br Heart J. 69(6): 556-62 (1993).
[CrossRef] [Google Scholar] [PubMed]
- Rosenthal E, Qureshi SA, Chan KC, et al. Radiofrequency-assisted balloon dilatation in patients with pulmonary valve atresia and an intact ventricular septum. Br Heart J. 69(4): 347-51 (1993).
[CrossRef] [Google Scholar] [PubMed]
- Lamers L, Garn B, Ellsworth E, et al. Decreased incidence of right-ventricular outflow tract complications using a retrograde snare technique for radiofrequency pulmonary valve perforation. Pediatr Cardiol. 33(8): 1275-80 (2012).
[CrossRef] [Google Scholar] [PubMed]
- Buller CE. Coronary guidewires for chronic total occlusion procedures: Function and design. Interv Cardiol. 5(5): 533-540 (2013).
[CrossRef] [Google Scholar] [PubMed]
- Sizarov A, Boudjemline Y. Novel materials and devices in the transcatheter creation of vascular anastomosis--the future comes slowly (part 2). Arch Cardiovasc Dis. 109(4): 286-95 (2016).
[CrossRef] [Google Scholar] [PubMed]
- Odemis E, Uslu N, Tanidir IC, et al. Conquest Pro 12 coronary guidewire for perforation of functionally interrupted aorta. Cardiol Young. 23(4): 623-5 (2013).
[CrossRef] [Google Scholar] [PubMed]